Global Ranitidine (Zantac) Market Growth 2022-2028


Mar, 2022 | Report ID: 225809 | 165 | Pharmaceuticals and Healthcare

As the global economy mends, the 2021 growth of Ranitidine (Zantac) will have significant change from previous year. According to our latest study, the global Ranitidine (Zantac) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Ranitidine (Zantac) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Ranitidine (Zantac) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ranitidine (Zantac) market, reaching US$ million by the year 2028. As for the Europe Ranitidine (Zantac) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Ranitidine (Zantac) players cover Sanofi-Aventis, GlaxoSmithKline, Hi-Tech Pharmacal Co., and Sun Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Ranitidine (Zantac) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Ranitidine Capsule

Ranitidine Oral Tablet

Ranitidine Injectable Solution

Ranitidine Oral Syrup

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Sanofi-Aventis

GlaxoSmithKline

Hi-Tech Pharmacal Co.

Sun Pharma

Mylan Pharmaceuticals Inc. (and Mylan Laboratories)

Dr. Reddy’s Laboratories Inc.

Sandoz Inc. (part of Novartis AG)

Strides (and Strides Arcolab international)

Geri-Care Pharmaceuticals

PAI Holdings, LLC

Teva Pharmaceuticals

Granules Pharmaceuticals Inc.

Glenmark Pharmaceuticals (and Glenmark Generics)

Apotex Inc. (and Apotex Corporation)

Hikma Pharmaceuticals (West-ward Pharmaceuticals)


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Ranitidine (Zantac) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Ranitidine (Zantac) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Ranitidine (Zantac) by Country/Region, 2017, 2022 & 2028

2.2 Ranitidine (Zantac) Segment by Type

2.2.1 Ranitidine Capsule

2.2.2 Ranitidine Oral Tablet

2.2.3 Ranitidine Injectable Solution

2.2.4 Ranitidine Oral Syrup

2.3 Ranitidine (Zantac) Sales by Type

2.3.1 Global Ranitidine (Zantac) Sales Market Share by Type (2017-2022)

2.3.2 Global Ranitidine (Zantac) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Ranitidine (Zantac) Sale Price by Type (2017-2022)

2.4 Ranitidine (Zantac) Segment by Application

2.4.1 Hospital Pharmacy

2.4.2 Retail Pharmacy

2.4.3 Online Pharmacy

2.5 Ranitidine (Zantac) Sales by Application

2.5.1 Global Ranitidine (Zantac) Sale Market Share by Application (2017-2022)

2.5.2 Global Ranitidine (Zantac) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Ranitidine (Zantac) Sale Price by Application (2017-2022)

3 Global Ranitidine (Zantac) by Company

3.1 Global Ranitidine (Zantac) Breakdown Data by Company

3.1.1 Global Ranitidine (Zantac) Annual Sales by Company (2020-2022)

3.1.2 Global Ranitidine (Zantac) Sales Market Share by Company (2020-2022)

3.2 Global Ranitidine (Zantac) Annual Revenue by Company (2020-2022)

3.2.1 Global Ranitidine (Zantac) Revenue by Company (2020-2022)

3.2.2 Global Ranitidine (Zantac) Revenue Market Share by Company (2020-2022)

3.3 Global Ranitidine (Zantac) Sale Price by Company

3.4 Key Manufacturers Ranitidine (Zantac) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Ranitidine (Zantac) Product Location Distribution

3.4.2 Players Ranitidine (Zantac) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Ranitidine (Zantac) by Geographic Region

4.1 World Historic Ranitidine (Zantac) Market Size by Geographic Region (2017-2022)

4.1.1 Global Ranitidine (Zantac) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Ranitidine (Zantac) Annual Revenue by Geographic Region

4.2 World Historic Ranitidine (Zantac) Market Size by Country/Region (2017-2022)

4.2.1 Global Ranitidine (Zantac) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Ranitidine (Zantac) Annual Revenue by Country/Region

4.3 Americas Ranitidine (Zantac) Sales Growth

4.4 APAC Ranitidine (Zantac) Sales Growth

4.5 Europe Ranitidine (Zantac) Sales Growth

4.6 Middle East & Africa Ranitidine (Zantac) Sales Growth

5 Americas

5.1 Americas Ranitidine (Zantac) Sales by Country

5.1.1 Americas Ranitidine (Zantac) Sales by Country (2017-2022)

5.1.2 Americas Ranitidine (Zantac) Revenue by Country (2017-2022)

5.2 Americas Ranitidine (Zantac) Sales by Type

5.3 Americas Ranitidine (Zantac) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Ranitidine (Zantac) Sales by Region

6.1.1 APAC Ranitidine (Zantac) Sales by Region (2017-2022)

6.1.2 APAC Ranitidine (Zantac) Revenue by Region (2017-2022)

6.2 APAC Ranitidine (Zantac) Sales by Type

6.3 APAC Ranitidine (Zantac) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Ranitidine (Zantac) by Country

7.1.1 Europe Ranitidine (Zantac) Sales by Country (2017-2022)

7.1.2 Europe Ranitidine (Zantac) Revenue by Country (2017-2022)

7.2 Europe Ranitidine (Zantac) Sales by Type

7.3 Europe Ranitidine (Zantac) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Ranitidine (Zantac) by Country

8.1.1 Middle East & Africa Ranitidine (Zantac) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Ranitidine (Zantac) Revenue by Country (2017-2022)

8.2 Middle East & Africa Ranitidine (Zantac) Sales by Type

8.3 Middle East & Africa Ranitidine (Zantac) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Ranitidine (Zantac)

10.3 Manufacturing Process Analysis of Ranitidine (Zantac)

10.4 Industry Chain Structure of Ranitidine (Zantac)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Ranitidine (Zantac) Distributors

11.3 Ranitidine (Zantac) Customer

12 World Forecast Review for Ranitidine (Zantac) by Geographic Region

12.1 Global Ranitidine (Zantac) Market Size Forecast by Region

12.1.1 Global Ranitidine (Zantac) Forecast by Region (2023-2028)

12.1.2 Global Ranitidine (Zantac) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Ranitidine (Zantac) Forecast by Type

12.7 Global Ranitidine (Zantac) Forecast by Application

13 Key Players Analysis

13.1 Sanofi-Aventis

13.1.1 Sanofi-Aventis Company Information

13.1.2 Sanofi-Aventis Ranitidine (Zantac) Product Offered

13.1.3 Sanofi-Aventis Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi-Aventis Main Business Overview

13.1.5 Sanofi-Aventis Latest Developments

13.2 GlaxoSmithKline

13.2.1 GlaxoSmithKline Company Information

13.2.2 GlaxoSmithKline Ranitidine (Zantac) Product Offered

13.2.3 GlaxoSmithKline Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline Main Business Overview

13.2.5 GlaxoSmithKline Latest Developments

13.3 Hi-Tech Pharmacal Co.

13.3.1 Hi-Tech Pharmacal Co. Company Information

13.3.2 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Product Offered

13.3.3 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Hi-Tech Pharmacal Co. Main Business Overview

13.3.5 Hi-Tech Pharmacal Co. Latest Developments

13.4 Sun Pharma

13.4.1 Sun Pharma Company Information

13.4.2 Sun Pharma Ranitidine (Zantac) Product Offered

13.4.3 Sun Pharma Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sun Pharma Main Business Overview

13.4.5 Sun Pharma Latest Developments

13.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories)

13.5.1 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Company Information

13.5.2 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Product Offered

13.5.3 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Main Business Overview

13.5.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Latest Developments

13.6 Dr. Reddy’s Laboratories Inc.

13.6.1 Dr. Reddy’s Laboratories Inc. Company Information

13.6.2 Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Product Offered

13.6.3 Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Dr. Reddy’s Laboratories Inc. Main Business Overview

13.6.5 Dr. Reddy’s Laboratories Inc. Latest Developments

13.7 Sandoz Inc. (part of Novartis AG)

13.7.1 Sandoz Inc. (part of Novartis AG) Company Information

13.7.2 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Product Offered

13.7.3 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sandoz Inc. (part of Novartis AG) Main Business Overview

13.7.5 Sandoz Inc. (part of Novartis AG) Latest Developments

13.8 Strides (and Strides Arcolab international)

13.8.1 Strides (and Strides Arcolab international) Company Information

13.8.2 Strides (and Strides Arcolab international) Ranitidine (Zantac) Product Offered

13.8.3 Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Strides (and Strides Arcolab international) Main Business Overview

13.8.5 Strides (and Strides Arcolab international) Latest Developments

13.9 Geri-Care Pharmaceuticals

13.9.1 Geri-Care Pharmaceuticals Company Information

13.9.2 Geri-Care Pharmaceuticals Ranitidine (Zantac) Product Offered

13.9.3 Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Geri-Care Pharmaceuticals Main Business Overview

13.9.5 Geri-Care Pharmaceuticals Latest Developments

13.10 PAI Holdings, LLC

13.10.1 PAI Holdings, LLC Company Information

13.10.2 PAI Holdings, LLC Ranitidine (Zantac) Product Offered

13.10.3 PAI Holdings, LLC Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 PAI Holdings, LLC Main Business Overview

13.10.5 PAI Holdings, LLC Latest Developments

13.11 Teva Pharmaceuticals

13.11.1 Teva Pharmaceuticals Company Information

13.11.2 Teva Pharmaceuticals Ranitidine (Zantac) Product Offered

13.11.3 Teva Pharmaceuticals Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Teva Pharmaceuticals Main Business Overview

13.11.5 Teva Pharmaceuticals Latest Developments

13.12 Granules Pharmaceuticals Inc.

13.12.1 Granules Pharmaceuticals Inc. Company Information

13.12.2 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Product Offered

13.12.3 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Granules Pharmaceuticals Inc. Main Business Overview

13.12.5 Granules Pharmaceuticals Inc. Latest Developments

13.13 Glenmark Pharmaceuticals (and Glenmark Generics)

13.13.1 Glenmark Pharmaceuticals (and Glenmark Generics) Company Information

13.13.2 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Product Offered

13.13.3 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Glenmark Pharmaceuticals (and Glenmark Generics) Main Business Overview

13.13.5 Glenmark Pharmaceuticals (and Glenmark Generics) Latest Developments

13.14 Apotex Inc. (and Apotex Corporation)

13.14.1 Apotex Inc. (and Apotex Corporation) Company Information

13.14.2 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Product Offered

13.14.3 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Apotex Inc. (and Apotex Corporation) Main Business Overview

13.14.5 Apotex Inc. (and Apotex Corporation) Latest Developments

13.15 Hikma Pharmaceuticals (West-ward Pharmaceuticals)

13.15.1 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Company Information

13.15.2 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Product Offered

13.15.3 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Main Business Overview

13.15.5 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Ranitidine (Zantac) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Ranitidine (Zantac) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Ranitidine Capsule

Table 4. Major Players of Ranitidine Oral Tablet

Table 5. Major Players of Ranitidine Injectable Solution

Table 6. Major Players of Ranitidine Oral Syrup

Table 7. Global Ranitidine (Zantac) Sales by Type (2017-2022) & (K Units)

Table 8. Global Ranitidine (Zantac) Sales Market Share by Type (2017-2022)

Table 9. Global Ranitidine (Zantac) Revenue by Type (2017-2022) & ($ million)

Table 10. Global Ranitidine (Zantac) Revenue Market Share by Type (2017-2022)

Table 11. Global Ranitidine (Zantac) Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Ranitidine (Zantac) Sales by Application (2017-2022) & (K Units)

Table 13. Global Ranitidine (Zantac) Sales Market Share by Application (2017-2022)

Table 14. Global Ranitidine (Zantac) Revenue by Application (2017-2022)

Table 15. Global Ranitidine (Zantac) Revenue Market Share by Application (2017-2022)

Table 16. Global Ranitidine (Zantac) Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Ranitidine (Zantac) Sales by Company (2020-2022) & (K Units)

Table 18. Global Ranitidine (Zantac) Sales Market Share by Company (2020-2022)

Table 19. Global Ranitidine (Zantac) Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Ranitidine (Zantac) Revenue Market Share by Company (2020-2022)

Table 21. Global Ranitidine (Zantac) Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Ranitidine (Zantac) Producing Area Distribution and Sales Area

Table 23. Players Ranitidine (Zantac) Products Offered

Table 24. Ranitidine (Zantac) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Ranitidine (Zantac) Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Ranitidine (Zantac) Sales Market Share Geographic Region (2017-2022)

Table 29. Global Ranitidine (Zantac) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Ranitidine (Zantac) Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Ranitidine (Zantac) Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Ranitidine (Zantac) Sales Market Share by Country/Region (2017-2022)

Table 33. Global Ranitidine (Zantac) Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Ranitidine (Zantac) Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Ranitidine (Zantac) Sales by Country (2017-2022) & (K Units)

Table 36. Americas Ranitidine (Zantac) Sales Market Share by Country (2017-2022)

Table 37. Americas Ranitidine (Zantac) Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Ranitidine (Zantac) Revenue Market Share by Country (2017-2022)

Table 39. Americas Ranitidine (Zantac) Sales by Type (2017-2022) & (K Units)

Table 40. Americas Ranitidine (Zantac) Sales Market Share by Type (2017-2022)

Table 41. Americas Ranitidine (Zantac) Sales by Application (2017-2022) & (K Units)

Table 42. Americas Ranitidine (Zantac) Sales Market Share by Application (2017-2022)

Table 43. APAC Ranitidine (Zantac) Sales by Region (2017-2022) & (K Units)

Table 44. APAC Ranitidine (Zantac) Sales Market Share by Region (2017-2022)

Table 45. APAC Ranitidine (Zantac) Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Ranitidine (Zantac) Revenue Market Share by Region (2017-2022)

Table 47. APAC Ranitidine (Zantac) Sales by Type (2017-2022) & (K Units)

Table 48. APAC Ranitidine (Zantac) Sales Market Share by Type (2017-2022)

Table 49. APAC Ranitidine (Zantac) Sales by Application (2017-2022) & (K Units)

Table 50. APAC Ranitidine (Zantac) Sales Market Share by Application (2017-2022)

Table 51. Europe Ranitidine (Zantac) Sales by Country (2017-2022) & (K Units)

Table 52. Europe Ranitidine (Zantac) Sales Market Share by Country (2017-2022)

Table 53. Europe Ranitidine (Zantac) Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Ranitidine (Zantac) Revenue Market Share by Country (2017-2022)

Table 55. Europe Ranitidine (Zantac) Sales by Type (2017-2022) & (K Units)

Table 56. Europe Ranitidine (Zantac) Sales Market Share by Type (2017-2022)

Table 57. Europe Ranitidine (Zantac) Sales by Application (2017-2022) & (K Units)

Table 58. Europe Ranitidine (Zantac) Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Ranitidine (Zantac) Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Ranitidine (Zantac) Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Ranitidine (Zantac) Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Ranitidine (Zantac) Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Ranitidine (Zantac) Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Ranitidine (Zantac) Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Ranitidine (Zantac) Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Ranitidine (Zantac) Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Ranitidine (Zantac)

Table 68. Key Market Challenges & Risks of Ranitidine (Zantac)

Table 69. Key Industry Trends of Ranitidine (Zantac)

Table 70. Ranitidine (Zantac) Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Ranitidine (Zantac) Distributors List

Table 73. Ranitidine (Zantac) Customer List

Table 74. Global Ranitidine (Zantac) Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Ranitidine (Zantac) Sales Market Forecast by Region

Table 76. Global Ranitidine (Zantac) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Ranitidine (Zantac) Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Ranitidine (Zantac) Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Ranitidine (Zantac) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Ranitidine (Zantac) Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Ranitidine (Zantac) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Ranitidine (Zantac) Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Ranitidine (Zantac) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Ranitidine (Zantac) Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Ranitidine (Zantac) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Ranitidine (Zantac) Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Ranitidine (Zantac) Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Ranitidine (Zantac) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Ranitidine (Zantac) Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Ranitidine (Zantac) Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Ranitidine (Zantac) Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Ranitidine (Zantac) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Ranitidine (Zantac) Revenue Market Share Forecast by Application (2023-2028)

Table 94. Sanofi-Aventis Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 95. Sanofi-Aventis Ranitidine (Zantac) Product Offered

Table 96. Sanofi-Aventis Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Sanofi-Aventis Main Business

Table 98. Sanofi-Aventis Latest Developments

Table 99. GlaxoSmithKline Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 100. GlaxoSmithKline Ranitidine (Zantac) Product Offered

Table 101. GlaxoSmithKline Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. GlaxoSmithKline Main Business

Table 103. GlaxoSmithKline Latest Developments

Table 104. Hi-Tech Pharmacal Co. Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 105. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Product Offered

Table 106. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Hi-Tech Pharmacal Co. Main Business

Table 108. Hi-Tech Pharmacal Co. Latest Developments

Table 109. Sun Pharma Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 110. Sun Pharma Ranitidine (Zantac) Product Offered

Table 111. Sun Pharma Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Sun Pharma Main Business

Table 113. Sun Pharma Latest Developments

Table 114. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 115. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Product Offered

Table 116. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Main Business

Table 118. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Latest Developments

Table 119. Dr. Reddy’s Laboratories Inc. Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 120. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Product Offered

Table 121. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Dr. Reddy’s Laboratories Inc. Main Business

Table 123. Dr. Reddy’s Laboratories Inc. Latest Developments

Table 124. Sandoz Inc. (part of Novartis AG) Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 125. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Product Offered

Table 126. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Sandoz Inc. (part of Novartis AG) Main Business

Table 128. Sandoz Inc. (part of Novartis AG) Latest Developments

Table 129. Strides (and Strides Arcolab international) Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 130. Strides (and Strides Arcolab international) Ranitidine (Zantac) Product Offered

Table 131. Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Strides (and Strides Arcolab international) Main Business

Table 133. Strides (and Strides Arcolab international) Latest Developments

Table 134. Geri-Care Pharmaceuticals Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 135. Geri-Care Pharmaceuticals Ranitidine (Zantac) Product Offered

Table 136. Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Geri-Care Pharmaceuticals Main Business

Table 138. Geri-Care Pharmaceuticals Latest Developments

Table 139. PAI Holdings, LLC Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 140. PAI Holdings, LLC Ranitidine (Zantac) Product Offered

Table 141. PAI Holdings, LLC Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. PAI Holdings, LLC Main Business

Table 143. PAI Holdings, LLC Latest Developments

Table 144. Teva Pharmaceuticals Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 145. Teva Pharmaceuticals Ranitidine (Zantac) Product Offered

Table 146. Teva Pharmaceuticals Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Teva Pharmaceuticals Main Business

Table 148. Teva Pharmaceuticals Latest Developments

Table 149. Granules Pharmaceuticals Inc. Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 150. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Product Offered

Table 151. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Granules Pharmaceuticals Inc. Main Business

Table 153. Granules Pharmaceuticals Inc. Latest Developments

Table 154. Glenmark Pharmaceuticals (and Glenmark Generics) Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 155. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Product Offered

Table 156. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. Glenmark Pharmaceuticals (and Glenmark Generics) Main Business

Table 158. Glenmark Pharmaceuticals (and Glenmark Generics) Latest Developments

Table 159. Apotex Inc. (and Apotex Corporation) Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 160. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Product Offered

Table 161. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 162. Apotex Inc. (and Apotex Corporation) Main Business

Table 163. Apotex Inc. (and Apotex Corporation) Latest Developments

Table 164. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Basic Information, Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 165. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Product Offered

Table 166. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 167. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Main Business

Table 168. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Latest Developments

List of Figures

Figure 1. Picture of Ranitidine (Zantac)

Figure 2. Ranitidine (Zantac) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Ranitidine (Zantac) Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Ranitidine (Zantac) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Ranitidine (Zantac) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Ranitidine Capsule

Figure 10. Product Picture of Ranitidine Oral Tablet

Figure 11. Product Picture of Ranitidine Injectable Solution

Figure 12. Product Picture of Ranitidine Oral Syrup

Figure 13. Global Ranitidine (Zantac) Sales Market Share by Type in 2021

Figure 14. Global Ranitidine (Zantac) Revenue Market Share by Type (2017-2022)

Figure 15. Ranitidine (Zantac) Consumed in Hospital Pharmacy

Figure 16. Global Ranitidine (Zantac) Market: Hospital Pharmacy (2017-2022) & (K Units)

Figure 17. Ranitidine (Zantac) Consumed in Retail Pharmacy

Figure 18. Global Ranitidine (Zantac) Market: Retail Pharmacy (2017-2022) & (K Units)

Figure 19. Ranitidine (Zantac) Consumed in Online Pharmacy

Figure 20. Global Ranitidine (Zantac) Market: Online Pharmacy (2017-2022) & (K Units)

Figure 21. Global Ranitidine (Zantac) Sales Market Share by Application (2017-2022)

Figure 22. Global Ranitidine (Zantac) Revenue Market Share by Application in 2021

Figure 23. Ranitidine (Zantac) Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Ranitidine (Zantac) Revenue Market Share by Company in 2021

Figure 25. Global Ranitidine (Zantac) Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Ranitidine (Zantac) Revenue Market Share by Geographic Region in 2021

Figure 27. Global Ranitidine (Zantac) Sales Market Share by Region (2017-2022)

Figure 28. Global Ranitidine (Zantac) Revenue Market Share by Country/Region in 2021

Figure 29. Americas Ranitidine (Zantac) Sales 2017-2022 (K Units)

Figure 30. Americas Ranitidine (Zantac) Revenue 2017-2022 ($ Millions)

Figure 31. APAC Ranitidine (Zantac) Sales 2017-2022 (K Units)

Figure 32. APAC Ranitidine (Zantac) Revenue 2017-2022 ($ Millions)

Figure 33. Europe Ranitidine (Zantac) Sales 2017-2022 (K Units)

Figure 34. Europe Ranitidine (Zantac) Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Ranitidine (Zantac) Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Ranitidine (Zantac) Revenue 2017-2022 ($ Millions)

Figure 37. Americas Ranitidine (Zantac) Sales Market Share by Country in 2021

Figure 38. Americas Ranitidine (Zantac) Revenue Market Share by Country in 2021

Figure 39. United States Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Ranitidine (Zantac) Sales Market Share by Region in 2021

Figure 44. APAC Ranitidine (Zantac) Revenue Market Share by Regions in 2021

Figure 45. China Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Ranitidine (Zantac) Sales Market Share by Country in 2021

Figure 52. Europe Ranitidine (Zantac) Revenue Market Share by Country in 2021

Figure 53. Germany Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Ranitidine (Zantac) Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Ranitidine (Zantac) Revenue Market Share by Country in 2021

Figure 60. Egypt Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Ranitidine (Zantac) Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Ranitidine (Zantac) in 2021

Figure 66. Manufacturing Process Analysis of Ranitidine (Zantac)

Figure 67. Industry Chain Structure of Ranitidine (Zantac)

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

Sample Request is not available